Table 3.
Baseline a | Month 3 visit | p‐value | Baseline a | Month 6 visit | p‐value | |
---|---|---|---|---|---|---|
Overall b , c | 38 (34%, 25 to 43) | 66 (58%, 49 to 68) | 0.0002 | 33 (33%, 24 to 42) | 48 (52%, 41 to 62) | 0.008 |
PrEP adherent d | 21/67 (31%, 20 to 42) | 36/60 (60%, 48 to 72) | 17/50 (34%, 21 to 47) | 27/49 (55% 41 to 69) | ||
Non‐PrEP adherent | 17/45 (38%, 24 to 52) | 30/53 (57%, 43 to 70) | 16/50 (32% 19 to 45) | 21/44 (48%, 33 to 62) |
Baseline figures based on availability of TFV‐DP results to match with self‐reported condom use data for corresponding follow‐up month analysed
p‐value of Z‐test for proportions comparing % of consistent condom use between month 3 versus month 6 = 0.329
No p‐values calculated from Z‐test for proportions comparing % of consistent condom use between PrEP adherent versus non‐adherent groups within visits reached 0.05
PrEP adherent defined as tenofovir‐diphosphate levels ≥700 fmol/punch.